WWW.JNEUROSCI.ORG
-
The Journal of Neuroscience
QUICK SEARCH:   [advanced]


     
-


HOME  |   SEARCH  |   ARCHIVE  |   SUBSCRIBE  |   CONTACT  |   HELP
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit an eLetter
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (77)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cepeda, C.
Right arrow Articles by Levine, M. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cepeda, C.
Right arrow Articles by Levine, M. S.

 Previous Article  |  Next Article 

The Journal of Neuroscience, February 1, 2003, 23(3):961

Transient and Progressive Electrophysiological Alterations in the Corticostriatal Pathway in a Mouse Model of Huntington's Disease

Carlos Cepeda1, Raymond S. Hurst1, Christopher R. Calvert1, Elizabeth Hernández-Echeagaray1, Oanh K. Nguyen1, Emily Jocoy1, Lindsey J. Christian1, Marjorie A. Ariano2, and Michael S. Levine1

1 Mental Retardation Research Center, University of California at Los Angeles, Los Angeles, California 90095, and 2 Department of Neuroscience, Chicago Medical School, North Chicago, Illinois 60064

Alterations in the corticostriatal pathway may precede symptomatology and striatal cell death in Huntington's disease (HD) patients. Here we examined spontaneous EPSCs in striatal medium-sized spiny neurons in slices from a mouse model of HD (R6/2). Spontaneous EPSC frequency was similar in young (3-4 weeks) transgenics and controls but decreased significantly in transgenics when overt behavioral symptoms began (5-7 weeks) and was most pronounced in severely impaired transgenics (11-15 weeks). These differences were maintained after bicuculline or tetrodotoxin, indicating they were specific to glutamatergic input and likely presynaptic in origin. Decreases in presynaptic and postsynaptic protein markers, synaptophysin and postsynaptic density-95, occurred in 11-15 week R6/2 mice, supporting the electrophysiological results. Furthermore, isolated, large-amplitude synaptic events (>100 pA) occurred more frequently in transgenic animals, particularly at 5-7 weeks, suggesting additional dysregulation of cortical inputs. Large events were blocked by tetrodotoxin, indicating a possible cortical origin. Addition of bicuculline and 4-aminopyridine facilitated the occurrence of large events. Riluzole, a compound that decreases glutamate release, reduced these events. Together, these observations indicate that both progressive and transient alterations occur along the corticostriatal pathway in experimental HD. These alterations are likely to contribute to the selective vulnerability of striatal medium-sized spiny neurons.

Key words: Huntington's disease; corticostriatal pathway; glutamatergic activity; EPSCs; mouse models; R6/2

Copyright © 2003 Society for Neuroscience  0270-6474/03/233961-09$05.00/0


This article has been cited by other articles:


Home page
 J. Neurosci.Home page
M. Gray, D. I. Shirasaki, C. Cepeda, V. M. Andre, B. Wilburn, X.-H. Lu, J. Tao, I. Yamazaki, S.-H. Li, Y. E. Sun, et al.
Full-Length Human Mutant Huntingtin with a Stable Polyglutamine Repeat Can Elicit Progressive and Selective Neuropathogenesis in BACHD Mice
J. Neurosci., June 11, 2008; 28(24): 6182 - 6195.
[Abstract] [Full Text] [PDF]

Home page
 J. Physiol.Home page
A. J. Milnerwood and L. A. Raymond
Corticostriatal synaptic function in mouse models of Huntington's disease: early effects of huntingtin repeat length and protein load
J. Physiol., December 15, 2007; 585(3): 817 - 831.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
H. B. Fernandes, K. G. Baimbridge, J. Church, M. R. Hayden, and L. A. Raymond
Mitochondrial Sensitivity and Altered Calcium Handling Underlie Enhanced NMDA-Induced Apoptosis in YAC128 Model of Huntington's Disease
J. Neurosci., December 12, 2007; 27(50): 13614 - 13623.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
E. C. Stack, A. Dedeoglu, K. M. Smith, K. Cormier, J. K. Kubilus, M. Bogdanov, W. R. Matson, L. Yang, B. G. Jenkins, R. Luthi-Carter, et al.
Neuroprotective Effects of Synaptic Modulation in Huntington's Disease R6/2 Mice
J. Neurosci., November 21, 2007; 27(47): 12908 - 12915.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurophysiol.Home page
N. Wu, C. Cepeda, X. Zhuang, and M. S. Levine
Altered Corticostriatal Neurotransmission and Modulation in Dopamine Transporter Knock-Down Mice
J Neurophysiol, July 1, 2007; 98(1): 423 - 432.
[Abstract] [Full Text] [PDF]

Home page
 Hum Mol GenetHome page
D. M. Cummings, A. J. Milnerwood, G. M. Dallerac, V. Waights, J. Y. Brown, S. C. Vatsavayai, M. C. Hirst, and K. P.S.J. Murphy
Aberrant cortical synaptic plasticity and dopaminergic dysfunction in a mouse model of huntington's disease
Hum. Mol. Genet., October 1, 2006; 15(19): 2856 - 2868.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurophysiol.Home page
V. M. Andre, C. Cepeda, A. Venegas, Y. Gomez, and M. S. Levine
Altered Cortical Glutamate Receptor Function in the R6/2 Model of Huntington's Disease
J Neurophysiol, April 1, 2006; 95(4): 2108 - 2119.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurophysiol.Home page
M. A. Ariano, C. Cepeda, C. R. Calvert, J. Flores-Hernandez, E. Hernandez-Echeagaray, G. J. Klapstein, S. H. Chandler, N. Aronin, M. DiFiglia, and M. S. Levine
Striatal Potassium Channel Dysfunction in Huntington's Disease Transgenic Mice
J Neurophysiol, May 1, 2005; 93(5): 2565 - 2574.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
N. K. Mazarakis, A. Cybulska-Klosowicz, H. Grote, T. Pang, A. Van Dellen, M. Kossut, C. Blakemore, and A. J. Hannan
Deficits in Experience-Dependent Cortical Plasticity and Sensory-Discrimination Learning in Presymptomatic Huntington's Disease Mice
J. Neurosci., March 23, 2005; 25(12): 3059 - 3066.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurophysiol.Home page
G. J. Klapstein and M. S. Levine
Age-Dependent Biphasic Changes in Ischemic Sensitivity in the Striatum of Huntington's Disease R6/2 Transgenic Mice
J Neurophysiol, February 1, 2005; 93(2): 758 - 765.
[Abstract] [Full Text] [PDF]

Home page
 Hum Mol GenetHome page
A. Petersen, J. Gil, M. L.C. Maat-Schieman, M. Bjorkqvist, H. Tanila, I. M. Araujo, R. Smith, N. Popovic, N. Wierup, P. Norlen, et al.
Orexin loss in Huntington's disease
Hum. Mol. Genet., January 1, 2005; 14(1): 39 - 47.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurophysiol.Home page
E. Bracci, D. Centonze, G. Bernardi, and P. Calabresi
Engagement of Rat Striatal Neurons by Cortical Epileptiform Activity Investigated With Paired Recordings
J Neurophysiol, November 1, 2004; 92(5): 2725 - 2737.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurophysiol.Home page
L. Li, T. H. Murphy, M. R. Hayden, and L. A. Raymond
Enhanced Striatal NR2B-Containing N-Methyl-D-Aspartate Receptor-Mediated Synaptic Currents in a Mouse Model of Huntington Disease
J Neurophysiol, November 1, 2004; 92(5): 2738 - 2746.
[Abstract] [Full Text] [PDF]

Home page
 Hum Mol GenetHome page
H. Li, T. Wyman, Z.-X. Yu, S.-H. Li, and X.-J. Li
Abnormal association of mutant huntingtin with synaptic vesicles inhibits glutamate release
Hum. Mol. Genet., August 15, 2003; 12(16): 2021 - 2030.
[Abstract] [Full Text] [PDF]


-

Home  |   Search  |   Archive  |   Subscribe  |   Contact  |   Help
-
Copyright 2008 by Society for Neuroscience ONLINE ISSN: 1529-2401
-